Psoriatic arthritis: therapeutic principles

Clinics in Dermatology

Volumn 26, Issue 5, 2008, Pages 460-463

  Feuchtenberger, Martin ^a   Kleinert, Stefan ^a   Tony, Hans Peter ^a   Kneitz, Christian ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EFALIZUMAB; ETANERCEPT; INFLIXIMAB; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PYRIDOXINE; SALAZOSULFAPYRIDINE; TACROLIMUS;

ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG SAFETY; ENTHESITIS; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTENSION; LIVER TOXICITY; MONOTHERAPY; PAIN; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; SKIN DEFECT; STOMACH ULCER; SWELLING; SYMPTOMATOLOGY; SYNOVIAL FLUID; TENDINITIS; TREATMENT FAILURE; TREATMENT RESPONSE; TUBERCULOSIS; UVEITIS;

EID: 49849089588     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2007.11.005     Document Type: Article

References (20)

1. Moll J.M., and Wright V. Psoriatic arthritis. Semin Arthritis Rheum 3 (1973) 55-78
2. Gladman D.D., Antoni C., Mease P., Clegg D.O., and Nash P. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis 64 Suppl 2 (2005) ii14-ii17
3. Leonard D.G., O'Duffy J.D., and Rogers R.S. Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis. Mayo Clin Proc 53 (1978) 511-518
4. Ritchlin C., Haas-Smith S.A., Hicks D., Cappuccio J., Osterland C.K., and Looney R.J. Patterns of cytokine production in psoriatic synovium. J Rheumatol 25 (1998) 1544-1552
5. Gladman D.D., Farewell V.T., Kopciuk H.A., and Cook R.J. HLA antigens and progression in psoriatic arthritis. J Rheumatol 25 (1998) 730-733
6. Gladman D.D., Anhorn K.A., Schachter R.K., and Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 13 (1986) 586-592
7. Mease P.J. Psoriatic arthritis therapy advances. Curr Opin Rheumatol 17 (2005) 426-432
8. Mease P.J., and Antoni C.E. Psoriatic arthritis treatment: biological response modifiers. Ann Rheum Dis 64 Suppl 2 (2005) ii78-ii82
9. Nash P., and Clegg D.O. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis 64 (2005) 74-77
10. Jones G., Brooks P., and Crotty M. Interventions for treating psoriatic arthritis. Cochrane Database Syst Rev 3 (2000) CD000212
11. Kaltwasser J.P., Nash P., Gladman D., et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 50 (2004) 1939-1950
12. Abu-Shakra M., Gladman D.D., Thorne J.C., et al. Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcomes. J Rheumatol 22 (1995) 241-245
13. Fraser A.D., van Kuijk A.W., Westhovens R., et al. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 64 (2005) 859-864
14. Mease P.J., Kivitz A.J., Burch F.X., et al. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 50 (2004) 2264-2272
15. Kavanaugh A., Antoni C.E., Gladman D., et al. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis 65 (2006) 1038-1043 [electronic publication 2006 Jan 26]
16. Gladman D.D., Mease P.J., Cifaldi M.A., Perdok R.J., Sasso E., and Medich J. Adalimumab improves joint- and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis 66 (2007) 163-168 [electronic publication 2006 Oct 17]
17. Kavanaugh A., Tutuncu Z., and Catalan-Sanchez T. Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis. Curr Opin Rheumatol 18 (2006) 347-353
18. Strober B.E. Successful treatment of psoriasis and psoriatic arthritis with etanercept and methotrexate in a patient newly unresponsive to infliximab. Arch Dermatol 140 (2004) 366
19. Winthrop K.L. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2 (2006) 602-610
20. Mease P.J., Gladman D.D., and Keystone E.C. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study. Arthritis Rheum 54/5 (2006) 1638-1645